[Progression from adenocarcinoma to small cell carcinoma of the prostate during endocrinotherapy: a case report].
A 72-year-old man had undergone surgical castration for metastatic prostate cancer (stage D2, the PSA value was 4,300 ng/ml) in September, 1997. He was well clinically for 16 months with undetected level of PSA. However, he presented with general malaise and gross hematuria in May, 1999. After admission to our hospital his condition rapidly deteriorated and he died one week later with respiratory failure. Autopsy revealed extensive involvement of the prostate and bladder by solid tumor with multiple metastases in lungs, liver, spleen, kidneys and bone. Histological examination revealed pure small cell carcinoma of the prostate.
Maeno
A
A
Department of Urology, Graduate School of Medicine, Kyoto University.
Kamoto
T
T
Kitamura
K
K
Kanno
T
T
Okuno
H
H
Terai
A
A
Kakehi
Y
Y
Terachi
T
T
Ogawa
O
O
Matsushiro
H
H
D000230:Adenocarcinoma / Q000473:pathology*; D000368:Aged; D001859:Bone Neoplasms / Q000556:secondary; D018288:Carcinoma, Small Cell / Q000473:pathology* / Q000556:secondary; D018450:Disease Progression; D006801:Humans; D007680:Kidney Neoplasms / Q000556:secondary; D008113:Liver Neoplasms / Q000556:secondary; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D011471:Prostatic Neoplasms / Q000473:pathology*; D013160:Splenic Neoplasms / Q000556:secondary